跳至主要内容
临床试验/NCT01431599
NCT01431599Unknown2 期

Two Week-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Rectal Cancer: Phase II Multicenter Clinical Trial (KROG 11-02)

Jong Hoon Lee3 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2011年9月最近更新:
适应症
干预措施

试验速览

阶段
2 期
发起方
Jong Hoon Lee
入组人数
80
试验地点
3
主要终点
downstaging effect of tumor

研究概览

简要总结

The purpose of this study is to evaluate the early clinical outcome of the short-course preoperative chemoradiotherapy, 33Gy/10 fx and delayed operation after chemoradiation, the investigators initiated the clinical trial of KROG 11-02.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • histologically confirmed adenocarcinoma
  • distal margin of the tumor located < 8 cm above the anal verge
  • cT3-4 or cN+ classification as determined by endorectal ultrasonography (EUS) and CT
  • patient older than age 18 years
  • Karnofsky performance score >= 70

排除标准

  • distant metastasis identified during staging workup
  • previous or concurrent malignancy
  • pregnant or breast-feeding women
  • impending rectal obstruction
  • familial adenomatous polyposis

研究组 & 干预措施

short-course

Experimental

干预措施: short-course radiation (Radiation)

结局指标

主要结局

downstaging effect of tumor

时间窗: an expected average of 6 weeks after chemoradiation

Comparison of clinical T staging and pathologic T staging example\> cT4 --\> pT1 after chemoradiation: down staging (+)

次要结局

  • bladder and small bowel toxicity after chemoradiation(Participants will be followed for an expected average of 3 months after chemoradiation)

研究者

发起方
Jong Hoon Lee
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jong Hoon Lee

Dr.

Seoul St. Mary's Hospital

研究点 (3)

Loading locations...

相似试验